title: In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy.
abstract: Recent advances in the application of bone marrow mesenchymal stem cells (BMMSC) for the treatment of tendon and ligament injuries in the horse suggest improved outcome measures in both experimental and clinical studies. Although the BMMSC are implanted into the tendon lesion in large numbers (usually 10 - 20 million cells), only a relatively small number survive (<10%) although these can persist for up to 5 months after implantation. This appears to be a common observation in other species where BMMSC have been implanted into other tissues and it is important to understand when this loss occurs, how many survive the initial implantation process and whether the cells are cleared into other organs. Tracking the fate of the cells can be achieved by radiolabeling the BMMSC prior to implantation which allows non-invasive in vivo imaging of cell location and quantification of cell numbers. This protocol describes a cell labeling procedure that uses Technetium-99m (Tc-99m), and tracking of these cells following implantation into injured flexor tendons in horses. Tc-99m is a short-lived (t1/2 of 6.01 hr) isotope that emits gamma rays and can be internalized by cells in the presence of the lipophilic compound hexamethylpropyleneamine oxime (HMPAO). These properties make it ideal for use in nuclear medicine clinics for the diagnosis of many different diseases. The fate of the labeled cells can be followed in the short term (up to 36 hr) by gamma scintigraphy to quantify both the number of cells retained in the lesion and distribution of the cells into lungs, thyroid and other organs. This technique is adapted from the labeling of blood leukocytes and could be utilized to image implanted BMMSC in other organs.
authors.affiliation: Department of Clinical Science and Services, The Royal Veterinary College; jdudhia@rvc.ac.uk.
authors.forename: Jayesh
authors.initials: J
authors.lastname: Dudhia
authors.affiliation: Hospital de Referencia La Equina, Manilva.
authors.forename: Patricia
authors.initials: P
authors.lastname: Becerra
authors.affiliation: Hospital de Referencia La Equina, Manilva.
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Valdés
authors.affiliation: Hospital de Referencia La Equina, Manilva.
authors.forename: Francisco
authors.initials: F
authors.lastname: Neves
authors.affiliation: Department of Nuclear Medicine, Barts & The London NHS Trust.
authors.forename: Neil G
authors.initials: NG
authors.lastname: Hartman
authors.affiliation: Department of Clinical Science and Services, The Royal Veterinary College.
authors.forename: Roger K W
authors.initials: RK
authors.lastname: Smith
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000000981:diagnostic imaging* / Q000473:pathology; D006734:Horse Diseases / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D006736:Horses; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods / Q000662:veterinary*; D059630:Mesenchymal Stem Cells / Q000000981:diagnostic imaging* / Q000473:pathology; D011877:Radionuclide Imaging / Q000379:methods / Q000662:veterinary; D013667:Technetium / Q000032:analysis / Q000737:chemistry*; D052256:Tendinopathy / Q000000981:diagnostic imaging / Q000628:therapy / Q000662:veterinary*; D013710:Tendons / Q000000981:diagnostic imaging* / Q000473:pathology
chemical_list: D013667:Technetium